85%Confidence
0Views
FDASource
2026-04-19Date
Summary
Redness relief eye drops from K.C. Pharmaceuticals exhibit sterility problems impacting industrial and pharmacy distribution channels. This expands the quality crisis to specialized markets, increasing regulatory and legal exposure.
Actionable: Review all eye care products in inventory for potential contamination risks from K.C. Pharmaceuticals.
AI Confidence: 85%
Data Points
firmK.C. Pharmaceuticals, Inc
classificationClass II
statusOngoing
distributionNationwide in the US
productSterile EYE DROPS REDNESS LUBRICANT (glycerin 0.25% and naphazoline HCl 0.012%), 0.5 fl oz (15 mL) bottles; a) Industrial Eye Relief, Distributed by:
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now